Literature DB >> 30254922

Elephant leg after treatment for endometrial cancer.

Joana Moreira-Barros1, Kuan-Gen Huang2,3, Tsung-Hsun Tsai2.   

Abstract

Entities:  

Year:  2017        PMID: 30254922      PMCID: PMC6135199          DOI: 10.1016/j.gmit.2017.06.001

Source DB:  PubMed          Journal:  Gynecol Minim Invasive Ther        ISSN: 2213-3070


× No keyword cloud information.
A 68 years-old patient, diabetic and history of endometrial cancer stage IB, managed with hysterectomy, bilateral pelvic lymphadenectomy and radiation therapy 12 years before, presented at the Emergency Department with fever and progressive left leg pain and swelling for 4 days. The patient referred chronic venous stasis and lymphedema since endometrial cancer surgery. Physical examination of the lower extremities showed bilateral edema, more marked on the left, which had also chronic changes of dependent edema, like hyperkeratosis, papillomatous plaques and cobblestone-like nodules, along with more acute changes that included erythema, heat and tenderness, resembling an “elephant leg” (see Fig. 1). The patient was admitted with the diagnosis of left leg lymphedema with secondary infection/cellulitis, treated with antibiotics (culture positive for Acinetobacter lwoffii).
Fig. 1

Bilateral lower limb edema, more evident on the left, with chronic and some acute changes, resembling an “elephant leg”.

Bilateral lower limb edema, more evident on the left, with chronic and some acute changes, resembling an “elephant leg”. The term elephantiasis is used to describe a body part that becomes enlarged and disfigured due to edema and fibrosis of the skin. Several conditions that block lymphatic drainage can induce lymphedema, including tumors, trauma, radiation therapy, congestive heart failure, chronic venous stasis, obesity, hypothy-roidism, and filarial infection. Elephantiasis nostras verrucosa is a rare and exaggerated form of secondary nonfilarial lymphedema.12 Surgical lymphadenectomy and radiation are common components of therapy for women with endometrial cancer and are thought to increase the risk of developing lower-extremity lymphedema. According to literature, the risk increases with the number and positivity of the lymph nodes dissected.34 These patients may also have comorbid conditions such as obesity and diabetes that further increase the risk. Once present, the symptoms and local effects of lymphedema cannot be cured, only managed.35 Some suggested strategies to prevent lymphedema formation include omission of lymphadenectomy in low risk patients; sentinel lymph node mapping - although long-term assessments are needed to demonstrate reduction of lymphedema in these patients -, and preservation of the distal most external iliac lymph node at the circumflex vein.5 The evidence on lower extremity lymphedema treatment and its efficacy is not yet robust.4 Initial therapy should be directed at relieving lymphedema with massage, compression stockings and multilayer inelastic lymphedema bandaging, after controlling of any infection and confirming adequate vascular perfusion. Decongestive lymphatic therapy, a form of complex physical therapy, and external sequential pneumatic compression devices, have also been applied. Pharmacological intervention with oral or topical retinoids has been successfully employed and can be added to physiotherapy. Surgical interventions, such as lymphaticovenular anastomosis or muscle flap transfer, have been used in most difficult and refractory cases of obstructive lymphedema.14 Hence, the resulting disability related to chronic lymphedema may lead to severe lifelong morbidity, including pain, skin breakdown and infection, impaired mobility, difficulties in self-care, psychosocial morbidity and impaired quality-of-life.35
  5 in total

1.  A case of elephantiasis nostras verrucosa.

Authors:  Yun-Seok Yang; Jae-Jun Ahn; Sik Haw; Min-Kyung Shin; Choong-Rim Haw
Journal:  Ann Dermatol       Date:  2009-08-31       Impact factor: 1.444

Review 2.  Lymphedema after treatment for endometrial cancer - A review of prevalence and risk factors.

Authors:  Emma Lindqvist; Madelene Wedin; Mats Fredrikson; Preben Kjølhede
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2017-02-22       Impact factor: 2.435

3.  Lymphedema after surgery for endometrial cancer: prevalence, risk factors, and quality of life.

Authors:  Kathleen J Yost; Andrea L Cheville; Mariam M Al-Hilli; Andrea Mariani; Brigitte A Barrette; Michaela E McGree; Amy L Weaver; Sean C Dowdy
Journal:  Obstet Gynecol       Date:  2014-08       Impact factor: 7.661

4.  The risk of lymphedema after postoperative radiation therapy in endometrial cancer.

Authors:  Devarati Mitra; Paul J Catalano; Nicole Cimbak; Antonio L Damato; Michael G Muto; Akila N Viswanathan
Journal:  J Gynecol Oncol       Date:  2015-10-08       Impact factor: 4.401

5.  Elephantiasis nostras verrucosa.

Authors:  Rafi Fredman; Mayer Tenenhaus
Journal:  Eplasty       Date:  2012-10-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.